ZOTA Zota Health Care Q2 FY26 results (Jul–Sep 2025) and concall
Zota Health Care reported a strong Q2 FY26 with consolidated revenue growing 92% year-on-year to INR 12,895 lakhs and EBITDA turning positive at INR 796 lakhs. The company continued its aggressive store expansion, reaching 2,055 outlets, and secured approval for a QIP of up to INR 500 crores to fund further growth. Management addressed concerns regarding store maturity, operating costs, and a perceived decline in mature store sales, emphasizing sustainable growth and operational efficiency.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q2 FY26: revenue up 68.5%, net profit up 321.7% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|
| Revenue | 59 | 68 | 78 | 78 | 99 +68% |
| EBITDA | 3 | 1 | 4 | 7 | 11 +233% |
| Net profit | 2 | 2 | 3 | 6 | 10 +322% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
